, Tracking Stock Market Picks
Enter Symbol:
AMAG Pharmaceuticals Inc. (AMAG) [hlAlert]

up 29.59 %

AMAG Pharmaceuticals Inc. (AMAG) upgraded to Buy by Citigroup

Posted on: Tuesday,  Jan 12, 2010  1:44 PM ET by Citigroup

Citigroup rated Buy AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) on 01/12/2010, when the stock price was $50.92. Since
then, AMAG Pharmaceuticals Inc. has gained 29.60% as of 01/25/2016's recent price of $65.99.
If you would have followed this Citigroup's recommendation on AMAG, you would have gained 29.59% of your investment in 2204 days.

Advanced Materials Group Inc. develops, manufactures and markets a wide variety of industrial products. The company's principal subsidiary, Advanced Materials, Inc., is the successor to a business that converts specialty materials including foams, foils, films and adhesive composites into components and finished products such as printer cartridge inserts and inking felts, disk drive gaskets, automobile air conditioning insulators, water and dust seals, surgical pads and applicators for the medical, electronics, automotive and consumer products markets.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/12/2010 1:44 PM Buy
as of 12/31/2010
1 Week down  -2.75 %
1 Month up  10.13 %
3 Months up  0.40 %
1 YTD down  -66.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2009 8:25 AM Hold
3/13/2009 8:25 AM Buy
28.83 37.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy